TY - JOUR AU - Belch, Jill J.F. AU - Hiat, William R. AU - Baumgartner, Iris AU - Vickie Driver, I. AU - Nikol, Sigrid AU - Largen, Lars AU - Vaquero Puerta, Carlos PY - 2011 UR - http://uvadoc.uva.es/handle/10324/2868 AB - Background Patients with critical limb ischaemia have a high rate of amputation and mortality. We tested the hypothesis that non-viral 1 fi broblast growth factor (NV1FGF) would improve amputation-free survival. Methods In this phase 3 trial... LA - eng PB - Lancet Publishing Group KW - Isquemia articular-tratamiento TI - Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limbischaemia DO - 10.1016/S0140-6736(11)60394-2 ER -